Truist analyst Scot Ciccarelli lowered the firm’s price target on Target to $133 from $137 and keeps a Hold rating on the shares. The company’s Q2 sales were weak as expected, including a 5.4% comp decline primarily driven by traffic, while its management has also reduced the full-year earnings outlook by about 9%, the analyst tells investors in a research note. Given the combination of weakening sales trends, implied share losses, and a less certain margin trajectory for 2024, a neutral stance is warranted, the firm adds.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TGT: